AAM Statement - President Trump’s Blueprint to Lower Drug Prices

#PassCREATES

Congress can pass the CREATES Act, which will stop the anti-competitive practices that are costing patients billions.

Learn More
Read the Biosimilars Council's New White Paper

Delivering More-Affordable, Innovative Medicines to America’s Patients

Read More
Skyrocketing Drug Prices Are a Threat to Everyone

Use this infographic to learn how generics and biosimilars are a remedy to sky-high health care costs.

Read Blog
Register for GRx+Biosims 2018

We’re uniting the power of innovation, science and policy to increase patient access to generic and biosimilar medicines.
View Video

Working to leave a positive impact on...

Industry

We promote competition in the pharmaceutical industry by lowering barriers to entry for manufacturers and combatting anti-competitive abuses by some brand drug companies who put profits before patients. Learn More

People

We measure our success as an industry by the lives we impact. We work to protect the low cost of current drugs and to drive down the cost of developing new ones, expanding access to as many people as possible. Learn More

Society

We are a trusted partner and established authority within the pharmaceutical field. We provide accurate, timely data to educate policymakers and promote general public knowledge regarding the positive impact of affordable medicines. Learn More

About Us

The Association for Accessible Medicines, formerly the Generic Pharmaceutical Association, improves access to safe, quality, effective medicine. Better access to medicine is relevant to everybody because, after all, we’re all patients at some point.

Health is the foundation for everything in life. Healthy people are better able to reach their full potential. Generics and biosimilars help more people in more places live healthier and longer.

Recent Updates

Senate Judiciary Committee Markup - CREATES Act

Jun 14, 2018 | Rachel Schwartz

AAM Statement on Senate Judiciary Committee Vote on CREATES Act

IGBA Joins ICH Management Committee

Jun 7, 2018 | Rachel Schwartz

IGBA Joins ICH Management Committee and Welcomes the Positive Vote of the General Assembly

Jun 6, 2018 | Jeff Watson

Pass the CREATES Act to End Manipulative Practices That Cost Our Patients Billions

May 31, 2018 | Rachel Schwartz

AAM Statement on FDA REMS Guidance

America's Opioid Epidemic: Youth Awareness & Prevention at Washington, DC's Newseum May 23, 2018 - Chip Davis

May 29, 2018 | Rachel Schwartz

AAM Speaks on Involvement in the Prescription Drug Safety Network

May 22, 2018 | Erica Klinger

Gold and Platinum Hermes Awards for AAM